Climb Bio CLYM
NASDAQ CLYM
$11.47 -0.03 (-0.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Climb Bio (CLYM) Capital Expenditures (2025)

Updated

Climb Bio (CLYM) posted Capital Expenditures of $186,000 for FY2025.

Analysis

Climb Bio (CLYM) Capital Expenditures (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Climb Bio 873.49 Mn 873.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 109,000.00
API Access

Climb Bio Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLYM&period=max&api_key=YOUR_API_KEY